GENEVA, Feb. 10 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo1018535) filed a patent application (PCT/JP2025/080111) for "COMPOUNDS AS SORT1 INHIBITORS" on Jul 28, 2025. With publication no. WO/2026/029204, the details related to the patent application was published on Feb 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): UEMATSU, Mika (c/o Otsuka Pharmaceutical Co., Ltd.3-2-27 OtedoriChuo-kuOsaka-shi, Osaka, 5400021), WOOLFORD, Alison Jo-Anne (c/o Astex Therapeutics Ltd, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA), TAKAHASHI, Haruka (c/o O...